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Skeletal muscle retains a resident stem cell population called satellite cells, which are mitotically
quiescent in mature muscle, but can be activated to produce myoblast progeny for muscle homeostasis,
hypertrophy and repair. We have previously shown that satellite cell activation is partially controlled by
the bioactive phospholipid, sphingosine-1-phosphate, and that S1P biosynthesis is required for muscle
regeneration. Here we investigate the role of sphingosine-1-phosphate receptor 3 (S1PR3) in regulating
murine satellite cell function. S1PR3 levels were high in quiescent myogenic cells before falling during
entry into cell cycle. Retrovirally-mediated constitutive expression of S1PR3 led to suppressed cell cycle
progression in satellite cells, but did not overtly affect the myogenic program. Conversely, satellite cells
isolated from S1PR3-null mice exhibited enhanced proliferation ex-vivo. In vivo, acute cardiotoxin-
induced muscle regeneration was enhanced in S1PR3-null mice, with bigger muscle ﬁbres compared to
control mice. Importantly, genetically deleting S1PR3 in the mdx mouse model of Duchenne muscular
dystrophy produced a less severe muscle dystrophic phenotype, than when signalling though S1PR3 was
operational. In conclusion, signalling though S1PR3 suppresses cell cycle progression to regulate function
in muscle satellite cells.
& 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.Introduction
Skeletal muscle retains a resident stem cell population called
satellite cells, located on the myoﬁbre surface (Mauro, 1961; Scharner
and Zammit, 2011). In adult, these cells participate in muscle home-
ostasis, hypertrophy and repair. When satellite cells are genetically
ablated though, skeletal muscle fails to regenerate (reviewed in
Relaix and Zammit, 2012). Satellite cells are normally mitotically
quiescent, but can be activated to enter the cell cycle and generate
myoblast progeny. Most of these cells then differentiate to produce
new myonuclei, while others self-renew to maintain the satellite cell
pool (Collins et al., 2005; Zammit et al., 2004). While growth factors
including HGF and FGFs are involved in the activation of satellite cells
(Ten Broek et al., 2010), the mechanisms controlling activation and
entry into cell cycle remain poorly understood.
Over the last few years the bioactive phospholipid, sphingosine-
1-phosphate (S1P), has emerged as an important regulator of
skeletal muscle function (Donati et al., 2013; Sabbadini et al.,r Inc.
it).
, Joondalup, WA, Australia.
Open access under CC BY license.1999). In Drosophila, perturbations in sphingosine levels lead to
defects in muscle development and integrity (Herr et al., 2003),
while elevation of intracellular S1P levels reduces muscle wasting in
ﬂies with dystrophic muscle (Pantoja et al., 2013). In mammals, S1P
affects calcium homeostasis, cell contraction and differentiation of
skeletal muscle (Donati et al., 2005; Formigli et al., 2002, 2009). We
have previously shown that S1P plays a crucial role in the entry of
satellite cells into the cell cycle (Nagata et al., 2006a, 2006b), and
more recent work substantiates this pro-mitogenic effect of S1P on
satellite cells (Calise et al., 2012; Loh et al., 2012). We also found that
muscle regeneration is compromised when S1P biosynthesis is
inhibited (Nagata et al., 2006b). Others have reported that S1P
levels increase during muscle regeneration via both control of S1P
biosynthesis and catabolism, and that muscle regeneration is
augmented when exogenous S1P is administered (Danieli-Betto
et al., 2010; Loh et al., 2012; Sassoli et al., 2011), conﬁrming its
central role in efﬁcient muscle regeneration. The effects of S1P on
myogenesis may not be restricted to satellite cells however, since
S1P also inﬂuences proliferation and survival in mesoangioblasts,
cells derived from the microvasculature with myogenic potential
(Donati et al., 2007).
S1P can activate ﬁve cell surface G-protein-coupled receptors
(S1PR1-5) that can operate through different signalling pathways
(Rosen et al., 2009). S1PR1-4 are expressed in satellite cells,
although their exact expression dynamics during myogenic
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2010; Donati et al., 2005; Meacci et al., 1999; Pallafacchina et al.,
2010). Ex-vivo, the mitogenic effects of S1P on satellite cells are
mediated by S1PR2, and maybe S1PR3 (Calise et al., 2012), with
S1P operating through at least S1PR2 in myogenic cells during
muscle regeneration in vivo (Germinario et al., 2012; Loh et al.,
2012). Finally, S1PR1 and S1PR3 appear to play antagonistic roles
during muscle regeneration, where S1PR1 negatively and S1PR3
positively modulates the early phases of muscle regeneration
(Danieli-Betto et al., 2010). Much of the work on the inﬂuence of
S1PR on muscle regeneration has been conducted using small
molecule antagonists and agonists. In particular, there are no
speciﬁc antagonists or agonists for S1PR3, making it difﬁcult to
uncouple effects of perturbed S1PR3 signalling from those of non-
S1PR3 effects (Pyne and Pyne, 2011; Salomone and Waeber, 2011).
Here we have characterized the role of the S1PR3 in skeletal
muscle satellite cells using constitutive retroviral-mediated
expression and knock-out mice to speciﬁcally examine S1PR3.
We found that S1PR3 expression is high in quiescent satellite cells
and C2 reserve cells, compared to the levels in proliferating
myoblasts. Since S1PR3 expression is down-regulated in prolifer-
ating myoblasts, we used retroviral-mediated constitutive expres-
sion to examine the effects of maintaining high S1PR3 levels in
proliferating satellite cell-derived myoblasts. This suppressed
myoblast proliferation, but did not overtly affect myogenic pro-
gression. To investigate satellite cell function and muscle regen-
eration in the absence of signalling through S1PR3, we examined
the S1PR3-null mouse (Ishii et al., 2001). Satellite cells isolated
from S1PR3-null mice exhibited enhanced proliferative ability. In
vivo, acute muscle regeneration following toxin-induced damage
was enhanced in S1PR3-null mice. We also used the mdx mouse
model of Duchenne muscular dystrophy to investigate if the
absence of S1PR3 improved chronic muscle regeneration, and
found that the dystrophic muscle phenotype was less severe in
S1PR3 //mdx mice. Therefore, signalling through S1PR3 sup-
presses cell cycle progression and so plays a role in controlling
satellite cell function.Materials and methods
Animals
Maintenance and genotyping of S1PR3-null mice were as
previously reported (Ishii et al., 2001). Heterozygotes were gener-
ated by breeding S1PR3-null mouse with C57 Bl/10 mice before
inter-crossing to obtain wild-type, heterozygote and knock-out
littermates and experiments performed using 6–10 week-old
(25–35 g) males. S1PR3-null and mdx mice were crossed and
female offspring were then crossed with a S1PR3-null male to
obtain mdx/S1PR3+/ and mdx/S1PR3 /- progeny. Breeding and
experimental procedures were passed by the Ethical Review
Process Committee of King′s College London, and carried out under
the provisions of the Animals (Scientiﬁc Procedures) Act 1986.Myoﬁbre isolation
To obtain isolated myoﬁbres, mice were killed by cervical
dislocation and the extensor digitorum longus (EDL) muscle care-
fully dissected, and manipulated only by its tendons. EDL muscles
were digested in 0.2% Collagenase Type 1 (Sigma, UK) in DMEM
(Sigma, UK) supplemented with 400 mM L-Glutamine (Sigma, UK)
and 1% (v/v) penicillin/streptomycin solution (Sigma, UK)] for
90 min at 37 1C. Individual myoﬁbres were then dissociated by
trituration using heat-polished glass Pasteur pipettes withvariously sized apertures and washed, as described in detail
elsewhere (Collins and Zammit, 2009; Rosenblatt et al., 1995).
Preparation of quiescent satellite cells
To prepare quiescent satellite cells as near to mitotic quiescence
as possible, freshly isolated myoﬁbres were mildly digested with
0.125% trypsin-EDTA (Sigma, UK) for 12 min at 37 1C, before
satellite cells were liberated using a heat-polished glass Pasteur
pipette. Satellite cells were separated from myoﬁbres and debris
by ﬁrst passing through a 40 μm cell sieve (BD Bioscience)
followed by two rounds of centrifugation at 1000 rpm with PBS
washes. Since little RNA can be obtained from quiescent satellite
cells, myoﬁbres from 4 to 6 EDL muscles were pooled for obtaining
quiescent satellite cells for each replicate, and three replicates
prepared (Knopp et al., 2013).
Non-adherent myoﬁbre culture
To study satellite cell-derived myoblasts while they remain
retained on a myoﬁbre, isolated myoﬁbres were incubated in
suspension in plating medium [DMEM with 10% (v/v) horse serum
(PAA Laboratories, UK), 0.5% (v/v) chick embryo extract (ICN Flow),
400 mM L-glutamine (Sigma, UK) and 1% (v/v) penicillin/streptomy-
cin solution (Sigma, UK)] in 50 mm18 mm non-tissue culture petri
dishes (Sterilin 124) coated with 0.1% BSA/PBS at 37 1C in 5% CO2.
Preparation of satellite cell-derived primary myoblasts
For adherent cultures, isolated myoﬁbres were plated in 6-well
plates (Nunc, UK) coated with 1 mg/ml Matrigel (Collaborative
Research). Plating mediumwas added and the cultures maintained
at 37 1C in 5% CO2. After 72 h in culture, myoﬁbres were removed,
and the remaining satellite cell-derived myoblasts trypsinised and
re-plated in Matrigel-coated LAB-TEK 8-well chamber slides
(Nunc, UK) and expanded using growth medium [DMEM supple-
mented with 30% (v/v) foetal calf serum, 10% (v/v) horse serum,
1% (v/v) chick embryo extract, 10 ng/ml bFGF, 400 mM L-glutamine
(Sigma, UK) and 1% (v/v) penicillin/streptomycin solution (Sigma)].
For EdU experiments, bFGF was omitted from the proliferation
medium. To induce differentiation, myoblasts were cultured in
DMEMGlutamax (Invitrogen) with v/v 2% horse serum (Gibco) and
1% (v/v) penicillin/streptomycin solution (Sigma, UK)].
Quantitative RT-PCR
Total RNA was extracted using the RNeasy Kit (Qiagen, UK) and
cDNA prepared from 100 to 500 ng of RNA with the QuantiTect
Reverse Transcription Kit with genomic DNA wipeout (Qiagen,
UK). QPCR was performed on an Mx3005P QPCR system (Strata-
gene, UK) with Brilliant II SYBR green reagents and ROX reference
dye (Stratagene, UK). Primers used in this study were: s1p1
(forward 5′-TCATAGTCCGGCATTACAACTA-3′, reverse 5′-GTGTG-
AGCTTGTAAGTGGTG-3′), s1p2 (forward -GCAGTGACAAAAGCTGCC-
GAATGCTGATG-3′; reverse 5′AGATGGTGACCACGCAGAGCACGTA-
GTG-3′), s1p3 (forward 5′ TCAGTATCTTCACCGCCATT-3′; reverse
5′-AATCACTACGGTCCGCAGAA-3′), Gapdh (forward 5′ GTGAAGG-
TCGGTGTGAACG 3′, reverse 5′ ATTTGATGTTAGTGGGGTCTCG 3′),
p27 (Cdkn1b) (forward 5′GTGGACCAAATGCCTGACTC 3′, reverse 5′
TCTTCTGTTCTGTTGGCCCT 3′), myogenin (forward 5′ CTACAGGC-
CTTGCTCAGCTC 3′, reverse 5′ AGATTGTGGGCGTCTGTAGG 3′).
Retroviral expression vectors
The retroviral backbone pMSCV-puro (Clontech) was modiﬁed
to replace the puromycin selection gene with eGFP, to create
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et al., 2006). Murine S1PR cDNAs (S1PR1 NM_007901.5; S1PR2
NM_010333.4; S1PR3 NM_010101.4) were individually cloned into
pMSCV-IRES-eGFP to generate pMSCV-S1PR1-IRESeGFP, pMSCV-
S1PR2-IRESeGFP or pMSCV-S1PR3-IRESeGFP, producing eachreceptor as a bicistronic message with eGFP. Constructs were
sequenced and veriﬁed by qPCR. Retroviral constructs, together
with an ecotropic packaging plasmid, were transiently co-
transfected into 293T cells to produce non-replicating retrovirus
and the supernatant harvested.
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A total of 5000 primary myoblasts were plated in each well of
LAB-TEK 8-well chamber slides (Nunc, UK). After 24 to 48 h, the
medium was replaced with a 1:5 dilution of 293T retroviral
supernatant with 4 mg/ml polybrene and incubated at 37 1C for
6 h, before cells were rinsed and placed in fresh medium. To infect
satellite cells associated with myoﬁbres, they were exposed to a
1:10 dilution of the supernatant after 24 h in culture, and the cells
were then analysed 48 h later.
Immunocytochemistry
Primary antibodies used were: mouse monoclonal anti-Pax7
and anti-myogenin clone F5D (Developmental Studies Hybridoma
Bank, Iowa, USA); mouse monoclonal anti-MyoD clone 5.8A
(DakoCytomation); rabbit polyclonal anti-MyoD (Santa Cruz Bio-
technology); polyclonal rabbit anti-GFP (Invitrogen); rat mono-
clonal anti-Ki67 (Dako Ltd., Kyoto, Japan). Immunostaining was
performed as described in detail elsewhere (Beauchamp et al.,
2000). Species speciﬁc ﬂuorochrome-conjugated secondary anti-
bodies (Invitrogen) were then applied for 1–2 h, before mounting
in Vectashield mounting medium with DAPI (Vector Laboratories,
Inc.). The Click-iT EdU imaging kit (Invitrogen, LifeTechnologies,
Paisley, UK) was used as per the manufacturer′s instructions.
Immunostained myoﬁbres, plated cells or cryosections were
viewed on a Zeiss Axiophot 200M using Plan-Neoﬂuar lenses
(Zeiss, WelwynGarden City, Hertfordshire, UK), or on a Nikon
(Kingston upon Thames, Surrey, UK) C1si confocal using Plan-
Fluor lenses. Digital images were acquired with a ZeissAxioCam
HRm Charge-Coupled Device using AxioVision software
version 4.4.
Muscle regeneration
The left and right TA muscles of 6–8 week-old male hetero-
zygote or S1PR3-null mice were injected with 25 µl of 10 µM
cardiotoxin (Sigma). We used two injection regimes: either a
single cardiotoxin injection, with muscle analysed after 7 and 21
days, or three injections at one week intervals, with muscles
assayed 7 days after the ﬁnal injection (21 days). Muscles were
immediately frozen in isopentane cooled in liquid nitrogen and
stored at 80 1C. Transverse muscle sections were cut with a
cryostat and stained with haematoxylin and eosin to examine any
gross morphological differences. Quantiﬁcation of centrallyFig. 1. S1PR3 suppresses cell cycle progression in satellite cells (A) RNA was prepared fr
(QRC). After removal of myotubes, quiescent reserve cells were then stimulated to re-e
intervals for 6 h (2 h Stim., 4 h Stim. and 6 h Stim.). Levels of S1PRmRNAwas analysed by
and exit from cell cycle. S1PR3 was increased 43 fold in quiescent reserve cells compar
stimulated to re-enter the cell cycle, dropping to levels equivalent to those in proliferatin
derived myoblasts (P), and after 12 (D12), 24 (D24) and 72 h (D72) in differentiation me
were unchanged. (A) and (B) Values are mean7SEM fold change from levels in proliferat
signiﬁcant difference (po0.05) in gene expression from the level in proliferating cells u
cells stripped from freshly isolated EDL myoﬁbres (QSC) and compared to the levels in pl
S1PR3 was at signiﬁcantly higher levels in quiescent, versus proliferating or differentiati
from the levels in quiescent cells [po0.05] using a one-tailed T-test). (D)–(F) To determin
infected with retroviruses encoding either S1PR1 (S1PR1 RV), S1PR2 (S1PR2 RV) or S1PR3
a further 48 h before ﬁxation. (D) Cells were co-immunostained for eGFP (green) to iden
together with DAPI counterstaining to identify all cells present. (E) Constitutive S1PR3 e
infection, while neither S1PR1 nor S1PR2 affected the proportion of proliferating cells. (F)
2 h before ﬁxation. Quantiﬁcation of immunostaining for eGFP and EdU revealed a s
expression, but not with S1PR1 or S1PR2, compared to control. (G) QPCR analysis of the r
with constitutive S1PR3 expression had higher expression of p27 (Cdkn1b) than contro
S1PR3, plated expanded satellite cells were infected and cultured for a further 2 days befo
in myotubes co-immunostaining for eGFP and MyHC showed a small decrease in the fus
S1PR3 RV-infected satellite cells showed that only S1PR3 expression showed a signiﬁcant
constitutive S1PR3 expression. Values in (D)–(I) are mean7SEM from three mice (n¼
po0.05 using a two-tailed T-test.nucleated regenerating myoﬁbres and measurement of myoﬁbre
cross sectional area were performed using ImageJ software (devel-
oped by NIH and available for free download at http://rsb.info.nih.
gov/ij).
Statistical analysis
Each experiment was repeated independently at least three
times (n¼3–6 depending on the experiment) and the mean from
multiple samples determined from each animal, and the popula-
tion mean7SEM calculated. Differences between test conditions
and controls were subjected to statistical analysis using
T-test in the Microsoft Excel Software (Microsoft Excel Corp.,
New York, USA). Statistical signiﬁcance was accepted at po0.05.
Details of numbers and statistical testing are given in ﬁgure
legends.Results
S1PR3 is expressed at a high level in quiescent myogenic cells
Higher S1PR3 expression in quiescent versus proliferating
satellite cells has been reported using microarray analysis
(Pallafacchina et al., 2010), and immunostaining with a non-
commercially available antibody has shown S1PR3 on quiescent
satellite cells (Danieli-Betto et al., 2010). We ﬁrst examined the
expression proﬁle of S1PR1, S1PR2 and S1PR3 in myogenic cells in
detail using the reserve cell model of induced myogenic quies-
cence (Yoshida et al., 1998). Proliferating C2C12 myoblasts were
induced to differentiate by serum withdrawal and 7 days later, the
reserve cells were separated from myotubes by differential trypsi-
nization, and gene expression levels measured by QPCR. Compared
to the levels in proliferating C2 cells, we found that S1PR1 was
slightly increased in myotubes while S1PR2 levels fell, with S1PR3
remaining unchanged. By contrast in quiescent reserve cells, while
S1PR2 was increased 6.5 fold, S1PR3 levels were 43 fold higher
(Fig. 1A). The cell cycle inhibitor p27 (Cdkn1b) was also signiﬁ-
cantly increased in both myotubes and reserve cells, conﬁrming
exit from the cell cycle. Stimulating reserve cells with high-serum
medium results in their rapid re-entry into the cell cycle, as shown
by the drop in p27 (Cdkn1b) levels by 2 h. Measuring gene
expression at 2 h intervals revealed that S1PR3 levels also fell
dramatically, becoming indistinguishable from the amount in
proliferating cells by 6 h after stimulation (Fig. 1A). Even by 6 hom either proliferating (P), differentiated (myotubes) or quiescent reserve C2 cells
nter the cell cycle by exposure to high-serum medium, and RNA prepared at 2 h
QPCR, withMyogenin and p27 (Cdkn1b) used as internal controls for differentiation
ed to levels in proliferating C2 cells. S1PR3 levels then fell as the reserve cells were
g C2 cells by 6 h. (B) RNA was also prepared from plated proliferating satellite cell-
dium. Levels of S1PR1 rose during differentiation, while those of S1PR2 and S1PR3
ing cells from three separate experiments or mice (n¼3), where an asterisk denotes
sing a two-tailed T-test. (C) S1PR3 expression was measured in RNA from satellite
ated proliferating (P) and differentiating (D12–D72) satellite cell-derived myoblasts.
ng cells (mean7SEM from 3 mice, where an asterisk denotes signiﬁcant difference
e the effects of constitutive expression of S1PR, plated expanded satellite cells were
(S1PR3 RV) as a bicistronic message with IRES-eGFP, or control RV, and cultured for
tify infected cells and Ki67 (red) to determine whether the cell was in the cell cycle,
xpression resulted in signiﬁcantly fewer cells in the cell cycle compared to Ctrl RV
Infected proliferating satellite cell-derived myoblasts were also pulsed with EdU for
igniﬁcant decrease in the proliferation rate of myoblasts with constitutive S1PR3
elative expression levels of p27 (Cdkn1b) in infected satellite cells showed that cells
ls. (H) To examine differentiation in the presence of constitutive S1PR1, S1PR2 or
re switching to differentiation medium for 2 days and ﬁxed. Quantiﬁcation of nuclei
ion index in S1PR3 RV-infected satellite cell-derived myoblasts. (I) QPCR analysis of
change (increase) relative to control RV, with S1PR1 and S1PR2 levels unaffected by
3), where an asterisk denotes signiﬁcantly different from control infection, with
Fig. 2. S1PR3-null satellite cells have increased proliferation. (A) EDL myoﬁbres were isolated from age-matched wild-type or S1PR3-null mice and immunostained for Pax7
to identify quiescent satellite cells. There was no difference in the number of quiescent satellite cells per EDL myoﬁbre in 6–8 week old S1PR3-null or wildtype mice. (B) and
(C) Satellite cells associated with a myoﬁbre from S1PR3 / and control mice were cultured for 72 h and co-immunostained for Pax7 (green) and Ki67 (red), with DAPI
counterstaining, to assess proliferation and self-renewal. A signiﬁcantly lower proportion of satellite cells lacking S1PR3 exited the cell cycle to adopt the self-renewal
phenotype compared to wild type cells. (D) Satellite cells associated with a myoﬁbre from S1PR3 / and control mice were cultured in medium to promote satellite cell
proliferation and samples pulsed with EdU for 4 h and ﬁxed at 24 h intervals. More S1PR3-null satellite cells had incorporated EdU after 48 and 72 h, compared to controls.
(E) and (F) Plated expanded satellite cell-derived myoblasts were cultured in serum-rich medium and pulsed for 2 h with EdU before ﬁxation. Co-staining for EdU and DAPI
conﬁrmed that more satellite cells from S1PR3-null mice incorporated EdU compared to control cells. Values are mean7SEM from three mice (n¼3) where an asterisk
denotes signiﬁcantly different from wild-type controls (po0.05) using a two-tailed T-test.
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proliferating cells (Fig. 1A).
We then determined the dynamics of S1PR expression in primary
murine satellite cells during myogenic progression. Myoﬁbres from
mouse EDL muscles were isolated by collagenase digestion, and the
muscle ﬁbres plated on Matrigel-coated tissue culture dishes. Once
satellite cell-derived myoblasts had accumulated around myoﬁbres,
the muscle ﬁbres were removed, and the cells passaged, pooled and
re-plated. RNA was prepared from proliferating cells, and after 12, 24
and 72 h in differentiation medium (Fig. 1B). Compared to the levels
in proliferating satellite cell-derived myoblasts, the levels of S1PR1
rose signiﬁcantly during myogenic differentiation, while S1PR2 and
S1PR3 expression was unaltered (Fig. 1B).
Since S1PR3 in particular, is expressed at much higher levels in
C2 reserve cells compared to those in proliferation, we attempted to
determine if this was also the case for satellite cells. To obtain RNA
from satellite cells as near to mitotic quiescence as possible, cells
were stripped from freshly isolated EDL myoﬁbres from several
mice and pooled. S1PR3 levels were measured by QPCR in parallelwith proliferating satellite cell-derived myoblasts and during myo-
genic differentiation. Expression of S1PR3was signiﬁcantly higher in
quiescent satellite cells compared to either proliferating or differ-
entiating satellite cells (Fig. 1C). Thus S1PR3 levels are higher in
quiescent myogenic cells than those in the cell cycle.
Constitutive S1PR3 expression suppresses cell cycle progression
Since S1PR3 is normally down-regulated in proliferating myogenic
cells, we set out to determine the effects of maintaining high S1PR3
expression throughout the cell cycle. Retroviruses were generated to
express S1PR1 (S1PR1 RV), S1PR2 (S1PR2 RV) or S1PR3 (S1PR3 RV),
together with an IRES-controlled eGFP. Plated, expanded proliferating
satellite cell-derived myoblasts from the EDL were infected with
either S1PR-expressing- or control retrovirus (containing no insert),
and cultured for 48 h, before being ﬁxed and immunostained for the
cell cycle marker Ki67 and eGFP. Satellite cells over-expressing S1PR1
or S1PR2 (eGFP+ve) behaved as those infected with control retrovirus,
with 50% of cells in the cell cycle as shown by nuclear Ki67. By
Fig. 3. Myogenic progression in S1PR3-null satellite cells is relatively normal. EDL myoﬁbres and their associated satellite cells were isolated from either age-matched wild-
type (S1PR3+/+) or S1PR3-null (S1PR3 /) mice and cultured in proliferation medium for 72 h. (A)–(C) Samples were taken at 24 h intervals, ﬁxed and co-immunostained for
Pax7, MyoD and Myogenin, which showed a general increase in each population when S1PR3 was absent, consistent with enhanced proliferation. (D) When expressed as a
ratio though, the proportions of cells expressing Pax7, MyoD or myogenin were similar between wildtype and S1PR3-null mice. (E) and (F) Expanded satellite cell-derived
myoblasts were also plated at high conﬂuency and then cultured in differentiation medium for 48 h before immunostaining for Myosin Heavy Chain (MyHC) and
counterstaining with DAPI. Counting the number of nuclei within MyHC+ve myotubes (42 nuclei) to determine the fusion index revealed that more satellite cells from
S1PR3-null mice had differentiated and fused than from control mice ((E), quantiﬁed (F)). Values are expressed as mean7SEM from multiple samples from at least three
mice (n¼3/4) where an asterisk denotes signiﬁcantly different (po0.05) from wild-type controls using a two-tailed T-test.
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retroviral-mediated expression of S1PR3 contained nuclear Ki67
(Fig. 1D and E), showing that S1PR3 promotes cell cycle exit. We also
pulsed infected proliferating satellite cells with EdU for 2 h and
examined the level of incorporation. Signiﬁcantly fewer cells over-
expressing S1PR3 (eGFP+ve) contained EdU, compared to those
expressing control retrovirus: revealing a decreased proliferation rate
in satellite cells with retroviral-mediated expression of S1PR3 (Fig. 1F).
The proliferation rate of cells expressing SIPR1 or S1PR2 was
unchanged from controls (Fig 1F). Consistent with these observations,
retroviral-mediated S1PR3 expression in satellite cells signiﬁcantly
increased levels of the cell cycle inhibitor p27 (Cdkn1b) (Fig. 1G).
We next investigated if retroviral-mediated expression of S1PR1,
S1PR2 or S1PR3 affected myogenic differentiation. Satellite cells were
infected with S1PR1 RV, S1PR2 RV, S1PR3 RV or control RV and then
cultured for a further 2 days, before being switched to differentiation
medium for 2 days before ﬁxation, by which time there was extensive
fusion into multinucleated myotubes. Co-immunostaining for myosin
heavy chain (MyHC) and eGFP was performed and the percentage of
nuclei within MyHC/eGFP+ve myotubes (deﬁned as having 2 or more
nuclei) determined to calculate the fusion index. This revealed that
there was a small, but signiﬁcant, decrease in myogenic differentiation
following retroviral-mediated expression of S1PR3 (Fig. 1H). Despite
the increased expression of S1PR1 in differentiating myoblasts, con-
stitutive expression of S1PR1 did not further enhance myoblast fusion
(Fig. 1H).
To determine if the decrease in proliferation in cells over-
expressing S1PR3 leads to precocious myogenic differentiation,
satellite cell-derived myoblasts were infected with S1PR3 RV and
control RV and after 24 h, given a 2 h EdU pulse and ﬁxed. Sister
cultures were then co-immunostained for either Pax7/eGFP or
myogenin/eGFP, combined with EdU detection. Again, there were
fewer eGFP+ve cells incorporating EdU after infection with S1PR3 RV
than control RV, but there was no change in the proportion of eGFP
+ve cells expressing Pax7 (70.572.1 for S1PR3 RV compared to
72.971.2 for control RV) or myogenin (23.371.2 for S1PR3 RV
compared to 21.372.1 for control RV).
To examine if increased S1PR3 levels in satellite cells due to
retroviral infection affected other S1PR, we measured S1PR1 and
S1PR2 by QPCR. Neither S1PR1 nor S1PR2 were signiﬁcantly
changed by retroviral-mediated constitutive S1PR3 expression,
while S1PR3 levels were signiﬁcantly elevated (Fig. 1I).S1PR3-null satellite cells have enhanced proliferation
We next examined the effects of an absence of signalling through
S1PR3 using S1PR3-null mice. While S1PR3-null mice have been
reported to have a reduced litter size, surviving mice do not have an
overt phenotype (Ishii et al., 2001), so provide a useful model to
examine the effects of S1PR3 on satellite cell function. We ﬁrst
examined by Q-PCR, whether the lack of signalling through S1PR3 in
S1PR3-null mice affected expression of S1PR1 or S1PR2 in muscle and
myogenic cells (Supplementary Fig. 1). S1PR1 levels were unaltered
in RNA from either whole EDL muscle or proliferating EDL satellite
cell-derived myoblasts, while S1PR2 expression was increased inFig. 4. Absence of S1PR3 enhances acute muscle regeneration. (A) Both Tibialis Anterior
cardiotoxin, and removed either 7 or 21 days later, cryosectioned and stained with haemat
(CNM) showed that skeletal muscle regenerated successfully in the absence of S1PR3. (D) - (
TA of S1PR3-null mice compared to S1PR3+/ controls, with a bias towards larger size. (F)–(I
size of myoﬁbres. (J) Mice were also subjected to a more rigorous acute regeneration reg
Haematoxylin and eosin staining 7 days after the third injury revealed many centrally-nucle
this more challenging injury routine. (M) - (N) Myoﬁbres in regenerated muscle from S1PR3
bias towards a larger size. Values are mean7SEM of a minimum of 40 myoﬁbres from e
myoﬁbres with centronucleation per unit area, or from between 32 and 68 centrally-nucle
from 3 mice per genotype. For D, H and M, an asterisk denotes where S1PR3 / are signiﬁRNA from whole EDL muscle (Supplementary Fig. 1A) but not from
proliferating myoblasts (Supplementary Fig. 1B).
Immunostaining for Pax7 on freshly isolated intact EDL myo-
ﬁbres permits the number of quiescent satellite cells to be
counted. We found that there was no signiﬁcant difference in
the number of quiescent satellite cells per myoﬁbre between adult
(6–8 weeks of age) S1PR3-null and control wild-type mice
(Fig. 2A), indicating that loss of S1PR3 does not affect the
generation of satellite cells during development.
To address proliferation and self-renewal of satellite cells in the
absence of S1PR3, we cultured EDL myoﬁbres and their associated
satellite cells from S1PR3-null and wildtype control mice for 72 h,
before ﬁxation and co-immunostaining for Ki67 and Pax7 (Fig. 2B
and C). By 72 h, many satellite cells are adopting a phenotype
consistent with self-renewal, i.e. express Pax7 and are no longer
proliferating (Zammit et al., 2004). There was a signiﬁcantly lower
proportion of Pax7+/Ki67-ve satellite cells (considered to be
undergoing self-renewal) in S1PR3-null mice compared to controls
(20% versus 80%, respectively—Fig. 2B and C). Thus at a time
when many satellite cells are no longer proliferating in wildtype
mice, there are many still in the cell cycle when S1PR3 is
genetically inactivated.
To assess the proliferation rate of S1PR3-null satellite cells,
myoﬁbre-associated satellite cells were cultured, and samples pulsed
with EdU and ﬁxed at 24 h intervals. Myoﬁbres were co-
immunostained for MyoD and EdU and the number of cells per
myoﬁbre that had incorporated EdU counted. There was a signiﬁcant
increase in the number of EdU-containing satellite cells from S1PR3-
null mice after 48 and 72 h of culture, compared to wildtype controls
(Fig. 2D).
We also assessed proliferation in plated satellite cell-derived
myoblasts, as proliferation on myoﬁbres is limited by the entry of
cells into self-renewal or differentiation by approximately 72 h.
Satellite cells from S1PR3-null and wildtype mice were pulsed
with EdU for 2 h and then ﬁxed. A signiﬁcantly higher proportion
of satellite cells from S1PR3 / mice incorporated EdU, when
compared to cells isolated from controls (Fig. 2E, quantiﬁed
in Fig. 2F).Myogenic progression in S1PR3-null satellite cells is relatively
unaffected
Having found that a lack of S1PR3 enhances proliferation in
satellite cells, we then investigated whether it also affected the
myogenic program. EDL-derived myoﬁbres with their associated
satellite cells were cultured for 72 h, with samples ﬁxed at 24 h
intervals and co-immunostained for Pax7, MyoD or myogenin
(Zammit et al., 2004). There was a general increase in the number
of satellite cell-derived myoblast progeny (Fig. 3A–C), consistent with
the enhanced proliferation detected by the Ki67 and EdU pulsing
experiments (Fig. 2). Importantly, the proportion of satellite cells
expressing Pax7, MyoD and Myogeninwas similar betweenwild type
and S1PR3 / derived satellite cells (Fig. 3D), reinforcing the idea
that an increase in proliferation, rather than any overt modiﬁcation in
myogenic progression, is the main affect of the absence of S1PR3.muscles from either age-matched S1PR3+/ or S1PR3 / mice were injected with
oxylin and eosin. (B)–(C) The presence of myoﬁbres with centrally-located myonuclei
E) Myoﬁbres had a signiﬁcantly larger mean cross-sectional area (CSA) in regenerating
) After 21 days from the time of injury, there was no longer any difference in the mean
ime of three consecutive rounds of cardiotoxin-induced injury 7 days apart. (K)–(L)
ated myoﬁbres present, showing that S1PR3 / mice still regenerated effectively after
-null mice had a higher mean cross sectional area than in control heterozygotes with a
ach of 9–13 ﬁelds from multiple sections per animal for determining the number of
ated myoﬁbres from a single representative ﬁeld per animal for measuring CSA, each
cantly different (po0.05) from S1PR3+/ controls using a two-tailed T-test.
Fig. 5. Absence of S1PR3 improves the dystrophic muscle phenotype in mdxmice. Tibialis Anterior (TA) and Diaphragm (Diaph) from separate age-matched controlmdx/S1PR3+/
ormdx/S1PR3 / males were cryosectioned and stainedwith haematoxylin and eosin. (A)–(B) Tibialis Anterior muscle ofmdx/S1PR3 / had a signiﬁcant decrease in the number of
centrally nucleated myoﬁbres (CNM) per unit area compared to control mdx/S1PR3+/ mice. (C) Mean cross-sectional area (CSA) of myoﬁbres with
either peripherally-located and centrally-located myonuclei was also increased in mdx/S1PR3 / compared to control mdx/S1PR3+/ mice, (D) with a bias towards larger sized
centrally-nucleated myoﬁbres. (E) to (F) Diaphragm from mdx/S1PR3 / had signiﬁcantly fewer centrally nucleated myoﬁbres (CNM) compared to control mdx/S1PR3+/
littermates. (G) - (H) Cross-sectional area (CSA) of myoﬁbres per unit area was increased inmdx/S1PR3 / compared to controlmdx/S1PR3+/ mice, with a predominance of larger
myoﬁbres. Values are mean7SEM of between 300 and 492 myoﬁbres from each of 2–4 ﬁelds frommultiple sections per animal from 5 to 6 mice per genotype for determining the
degree of centronucleation in TA muscles, and of between 120 and 320 myoﬁbres from 3 to 8 ﬁelds from multiple sections per animal from 3 mice per genotype for assessing
centronucleation in diaphragm. CSA is mean7SEM from measuring between 31 and 76 myoﬁbres from a single representative ﬁeld per muscle per animal from 3 mice per
genotype. An asterisk denotes where mdx/S1PR3 / are signiﬁcantly different (po0.05) from mdx/S1PR3 /+ controls using two tailed T-test.
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expanded satellite cell-derived myoblasts were plated at high con-
ﬂuence and immediately switched to differentiation medium, to limit
any effects of differential proliferation rates. Two days later, cells
were ﬁxed and immunostained for Myosin Heavy Chain and counter-
stained with DAPI. Counting the number of nuclei within MyHC+ve
myotubes (42 nuclei) to determine the fusion index revealed that
more satellite cells from S1PR3-null mice had differentiated and
fused than from control mice (Fig. 3E, quantiﬁed Fig. 3F). Thus, lack of
S1PR3 increases proliferation and improves myogenic fusion, without
drastically affecting myogenic progression.
Acute muscle regeneration is improved in S1PR3-null mice
To assess satellite cell function in the absence of S1PR3 in vivo,
muscle regeneration following myotoxin-induced damage was ana-
lysed in S1PR3 / and control S1PR3+/ mice. A single intramuscular
injection of cardiotoxin was administered to each Tibialis Anterior
(TA) of S1PR3-null or control heterozygote mice and the muscles
analysed after 7 or 21 days of regeneration (Fig. 4A). Cryosections
were prepared for haematoxylin and eosin staining to examine gross
morphology. Skeletal muscle was able to robustly regenerate in mice
lacking S1PR3, as shown by the presence of many myoﬁbres with
centrally-located nuclei (a hallmark of myoﬁbre regeneration) (Fig. 4B,
C, F and G). After 7 days of regeneration, there was a signiﬁcantincrease in the mean myoﬁbre size in S1PR3 / compared to
S1PR3+/ mice, as determined by measuring cross-sectional area
(Fig. 4B, quantiﬁed in Fig. 4D and E). By 21 days after the initiation
of regeneration though, there was no longer any difference in
myoﬁbre size in TA muscles of S1PR3-null compared to control
S1PR3+/ mice (Fig. 4F, quantiﬁed in Fig. 4H and I).
We also subjected the TA to a more rigorous regime of repeated
acute regeneration with three intramuscular injections of cardiotoxin
at one-week intervals, with analysis 7 days after the ﬁnal injection
(21 days) (Fig. 4J). There was still a clear regenerative ability after this
more challenging regime of multiple rounds of muscle damage, with
S1PR3-null mice having many centrally nucleated myoﬁbres (Fig. 4K
and L). There was a signiﬁcant increase in the mean cross-sectional
area of muscle ﬁbres in the S1PR3-null mice after the muscle injury/
recovery program, with more large myoﬁbres present, indicating
enhanced regeneration (Fig. 4M and N).
Absence of S1PR3 improves the dystrophic muscle phenotype
in mdx mice
To also examine the effects of a lack of S1PR3 signalling on
chronic muscle regeneration, we examined the dystrophic pheno-
type in the mdx mouse model of Duchenne muscular dystrophy.
The mdx mouse undergoes chronic rounds of myoﬁbre degenera-
tion/regeneration from approximately 3 weeks of age (De la Porte
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mdx male mice that were either heterozygous for S1PR3 (control
mdx/S1PR3+/) or S1PR3-null (mdx/S1PR3 /).
TA and EDL muscles were removed from 8 week old control
mdx/S1PR3+/ and mdx/S1PR3 / males. No signiﬁcant difference
in weight was observed between the two genotypes, indicating no
gross hypertrophy in the absence of S1PR3 (data not shown).
Haematoxylin and eosin staining of cryosections revealed signiﬁ-
cantly less centronucleated myoﬁbres in mdx/S1PR3 / compared
to their control mdx/S1PR3+/ littermates (Fig. 5A, quantiﬁed in
Fig. 5B). There was also an increase in the size of both centronu-
cleated and peripherally nucleated myoﬁbres in mdx/S1PR3 /
compared to their control mdx/S1PR3+/ littermates (Fig. 5A,
quantiﬁed in Fig. 5C and D).
To conﬁrm the improvement in the phenotype ofmdx/S1PR3 /
mice compared to control mdx/S1PR3+/ we also analysed the
diaphragm, which is known to be particularly sensitive to the
absence of dystrophin in mdx mice (Stedman et al., 1991). Again,
the number of centronucleated ﬁbres was lower in mdx/S1PR3 /
compared to their control mdx/S1PR3+/ littermates (Fig. 5E, quan-
tiﬁed in Fig. 5F). There was also a general increase of the size of
myoﬁbres in the diaphragms ofmdx/S1PR3 / compared to control
mdx/S1PR3+/ mice (Fig. 5E, quantiﬁed in Fig. 5G and H).Discussion
Muscle regeneration is compromised when S1P biosynthesis is
inhibited (Nagata et al., 2006b), and S1P levels increase during
muscle regeneration via both control of S1P biosynthesis and
catabolism (Danieli-Betto et al., 2010; Loh et al., 2012). The main
cells responsible for muscle regeneration, satellite cells, are normally
mitotically quiescent but when needed, are recruited to produce
myoblasts to perform muscle repair. S1P stimulates entry of acti-
vated satellite cell into the cell cycle and promotes proliferation
(Calise et al., 2012; Loh et al., 2012; Nagata et al., 2006a, 2006b).
Here we continued examination of S1P signalling in the control
of satellite cell function by investigating the role of the S1PRs.
Murine myoblasts express S1PR1, S1PR2 and S1PR3 in a dynamic
fashion through myogenic progression. S1PR1 was expressed at
higher levels in differentiating myogenic cells compared to pro-
liferating, while levels of S1PR2 and S1PR3 were unchanged
through myogenic progression. Interestingly, S1PR3 was highly
expressed in C2 reserve cells and freshly isolated quiescent
satellite cells, compared to the low levels when these cells were
proliferating; results consistent with previous observations of high
S1PR3 expression in reserve cells (Rapizzi et al., 2008), and in
quiescent satellite cells using microarrays (Pallafacchina et al.,
2010) or by immunostaining (Danieli-Betto et al., 2010). S1PR3 is at
low levels in both satellite cells isolated from mdx mice and in
growing mice compared to quiescent satellite cells from mature
healthy muscle, likely reﬂecting their more active state during
growth and under dystrophic conditions (Pallafacchina et al.,
2010). Furthermore, a decrease of S1PR3 expression during the
ﬁrst week of regeneration has also been noted (Danieli-Betto et al.,
2010). Although, Danieli-Betto and collaborators report increased
levels of S1PR3 by western-blot of whole regenerating and
neonatal muscle (Danieli-Betto et al., 2010), satellite cells are likely
to contribute only a minor fraction of isolated protein. Our study
clearly associates quiescent myogenic cells with high S1PR3
expression, and much lower levels in the proliferative state.
To counter modulation of S1PR levels during myogenic pro-
gression, we used retroviral-mediated expression to examine the
effects of maintaining high S1PR levels on satellite cell function.
Constitutive expression of either S1PR1 or S1PR2 did not affect the
already robust myoblast proliferation or differentiation stimulatedby our culture conditions. S1PR2 is involved in mediating mito-
genic and/or differentiation effects of S1P in myogenic cells (Calise
et al., 2012; Germinario et al., 2012; Loh et al., 2012). Furthermore,
delayed muscle regeneration is seen if S1PR2 function is inhibited
using JTE-013 in wildtype mice, or in S1PR2 / mice (Germinario
et al., 2012). In our experiments, we saw no effects of S1PR2 over-
expression on proliferation, although it is likely that the cells are
already proliferating at a high rate.
Over-expression of S1PR3 suppressed cell cycle progression in
satellite cell-derived myoblasts, and caused a small reduction of fusion
into myobubes. Conversely, satellite cells isolated from S1PR3 / mice
exhibited enhanced proliferation, with cells often still proliferating
when wildtype cells were exiting the cell cycle and adopting a
phenotype consistent with self-renewal (Zammit et al., 2004). How-
ever, rather than any overt modiﬁcation in myogenic progression, the
proportion of satellite cells expressing Pax7, MyoD and Myogenin was
similar between wild type and S1PR3 /-derived satellite cells,
reinforcing the idea that an increase in proliferation is the main effect
of the absence of S1PR3. Increased proliferation can also be associated
with better differentiation in various cell types, including satellite cells
(Abou-Khalil et al., 2009), and S1PR3-null satellite cells differentiated
into myotubes more extensively. We tried to avoid any effect on
fusion of the enhanced proliferation in satellite cells lacking S1PR3 by
seeding them at high conﬂuence immediately before switching to
differentiation medium. However, the possibility that the increased
differentiation was partly because of a higher cell density due to the
greater proliferative ability of S1PR3-null cells cannot be excluded.
Although S1P is normally associated with pro-mitogenic effects
in many cell types (An et al., 2000; Harada et al., 2004), adminis-
tration of S1P can also inhibit cell division in proliferating C2 cells,
which is prevented by inhibition of S1PR1 or S1PR2 (Donati et al.,
2005; Rapizzi et al., 2008). Furthermore, S1PR2 can block PDGF-
induced proliferation of murine embryonic ﬁbroblasts and rat
hepatocytes (Goparaju et al., 2005; Ikeda et al., 2003) and S1PR5
inhibits proliferation of human oesophageal cancer cells whether it
binds S1P or not (Hu et al., 2010). Previous studies reveal that S1PR3
is associated with promoting proliferation in mesangial cells and
myoﬁbroblasts, and also in certain pathogenic conditions (An, 2000;
Hsu et al., 2012; Katsuma et al., 2002; Wu et al., 2008), but, to our
knowledge, there are no other reports of S1PR3 suppressing pro-
liferation. Calise et al. demonstrated that S1P augments proliferation
in serum-starved satellite cells, which is reduced by exposure to
various small-molecule inhibitors, indicating that S1PR1-4 were all
involved in the pro-mitogenic effects of S1P (Calise et al., 2012).
However, as the authors acknowledge, the antagonists are not
speciﬁc, with CAY10444 or BLM241 used to block S1PR3 having
been reported to be non-speciﬁc (Jongsma et al., 2006). SiRNA
against each S1PR revealed that only the knockdown of either S1PR2
or S1PR3 mRNA reduced S1P-induced proliferation (Calise et al.,
2012). We speculate that the discrepancies between the two studies
arise from a combination of factors including; examining satellite
cells with transient, incomplete knockdown of S1PR3 using SiRNA
versus examining S1PR3-null satellite cells that have never
expressed S1PR3; examining siRNA-transfected satellite cells after
serum-starvation (for up to 22 h) and then in the presence of 1mM
SIP for another 20 h compared to examining S1PR3-null satellite
cells in standard high-serum proliferation medium; potential off-
target effects of the siRNA versus germline-deletion of S1PR3. It
would be interesting to determine the effects of siRNA-mediated
S1PR3 knockdown in satellite cells cultured in standard high-serum
proliferation medium. It is also possible that S1PR3 may act
independently of S1P binding as demonstrated recently for S1PR1
in endothelial cells in response to biomechanical signals (Jung et al.,
2012) and that there might be cross-talk in signalling pathways
with other receptors types, such as IGF, PDGF and TGF-β (Donati
et al., 2013; Liu et al., 2010).
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that in the absence of S1PR3, acute regeneration was enhanced
after a single insult with bigger myoﬁbre present, with this effect
more pronounced after several rounds of injury. We also examined
chronic muscle regeneration using the mdx mouse model of
Duchenne muscular dystrophy, which undergoes continuous
cycles of muscle degeneration and regeneration (De la Porte
et al., 1999). Mdx mice lacking S1PR3 had an improved dystrophic
phenotype compared to their mdx littermates, with fewer myo-
ﬁbres with central nucleation (a hallmark of myoﬁbre regenera-
tion) and a larger mean myoﬁbre cross-sectional area in both
Tibialis Anterior and diaphragm (a severely affected muscle in mdx
mice—(Stedman et al., 1991)). Increased satellite cell proliferation
in the absence of S1PR3 would presumably generate more myo-
blasts allowing muscle repair to be enhanced during acute muscle
regeneration, producing bigger myoﬁbres. However, increased
satellite cell proliferation in the mdx model could reduce signs of
trauma (myoﬁbres with centrally-located myonuclei) since the
ongoing repair of damaged ﬁbres may be more efﬁcient, leading to
less need for complete myoﬁbre regeneration. This would also
result in an increased mean myoﬁbre size in mdx/S1PR3-null mice
compared to controls, as we observed. Interestingly, Loh and
colleagues recently showed in mdx muscle that S1P levels are
low and S1P catabolism is increased. The dystrophic muscle
phenotype in mdx mice was improved via pharmacological inhibi-
tion of sphingosine phosphate lyase through an S1PR2-dependent
mechanism involving suppression of Rac1 (Loh et al., 2012).
Elevation of intracellular S1P levels also suppresses muscle wast-
ing in ﬂies with dystrophic muscle, showing the conservation of
this signalling pathway (Pantoja et al., 2013).
S1PR3 / is a germline knockout, so S1PR3 is absent in all cell
types, including inﬂammatory cells and endothelial-associated peri-
cytes/mesoangioblasts, which could also contribute to enhanced
muscle regeneration. The initial characterization of the S1PR3 knock-
out mice did not show any change in the immune cell number
however (Ishii et al., 2001). Cell types from the microvasculature wall
such as pericytes/mesoangioblasts have myogenic potential and are
regulated by S1P, but S1P exerts its pro-mitogenic effects through
S1PR2, although S1PR3 is highly expressed (Donati et al., 2007).
Therefore, mesoangioblast function could be affected by loss of
S1PR3 signalling in S1PR3-null mice. S1PR3 is also involved in
endothelial cell barrier integrity, though its exact role remains
controversial. A more disrupted barrier in S1PR3-null mice could allow
more pericytes/mesoangioblasts to be released to participate inmuscle
regeneration, although several publications mention that S1PR3
activation, rather than removal, may increase barrier disruption (e.g.-
Singleton et al., 2007). However, the recent evidence that satellite cells
are responsible for muscle regeneration (e.g. Lepper et al., 2011
reviewed in Relaix and Zammit, 2012), combined with the clear effects
of lack of S1PR3 on satellite cell proliferation ex-vivo, indicates that
this is likely to be the major factor in the improved muscle repair that
we observe in S1PR3-null mice.
Having demonstrated a role of S1PR3 in satellite cell function and
myogenesis, the next challenge is to decipher the signalling pathways
downstream of this receptor. The sphingosine-1-phosphate receptors
belong to the GPCR family and so operate through different types of
G-proteins, which in turn, control multiple signalling pathways
involved in cell survival, migration and proliferation (Donati et al.,
2013; Spiegel and Milstien, 2003). Several candidates have been
associated with the role of S1PR3 in proliferation in other cell types
(Rosen et al., 2009) but which pathways act to mediate the effects of
S1PR3 in satellite cells is unclear. Smad3 is involved in S1PR3-
mediated myoﬁbroblast proliferation and differentiation (Keller
et al., 2007), and recent studies have elucidated the role of smad3
in satellite cell function (Ge et al., 2011; Ono et al., 2011). Smad3 is a
key player in the TGF-βmediated repression of myogenesis (Liu et al.,2001) and different studies have also described overlapping signal-
ling between S1P and TGF-β (Liu et al., 2010; Xin et al., 2004).
Another candidate is Erk, the phosphorylation of which can be
regulated by S1P signalling in different cell types and is associated
with proliferation (Rodgers et al., 2009). In C2C12, Erk has a bimodal
function, being necessary both for maintaining cells in an undiffer-
entiated state, and for the hypertrophy of myotubes (Wu et al., 2000).
A picture is emerging whereby signalling through S1PR3 may
contribute to control of satellite cell quiescence, while signalling
operating through S1PR2 may then drive S1P-mediated proliferation
and/or differentiation. Satellite cells are actively maintained in a
quiescent state (Dhawan and Rando, 2005; Montarras et al., 2013).
For example, the calcitonin receptor is highly expressed in quiescent
satellite cells, and signals to attenuate the entry of satellite cells into
the cell cycle, since addition of calcitonin blocks incorporation of
BrdU (Fukada et al., 2007). Similarly, the Tie2 receptor and its ligand
angiopoietin, are involved in satellite cell self-renewal, requiring re-
entry into quiescence (Abou-Khalil et al., 2009). More recently, Notch
signalling has also been demonstrated to be important for maintain-
ing satellite cell quiescence, since when it is inactivated by knocking
out RBP-J, satellite cells spontaneously activate and differentiate
without self-renewing, leading to depletion of the satellite cell pool
(Bjornson et al., 2011; Mourikis et al., 2011). Analysis of S1PR3
expression and function in other cells types will illuminate if S1PR3
is a global regulator of quiescence.
In conclusion, we have shown that S1PR3 is highly expressed in
quiescent myoblasts and falls as they activate and enter the cell
cycle. If expression of S1PR3 is maintained in proliferating cells,
this then leads to slower progression through the cell cycle, while
lack of signalling through S1PR3 enhances proliferation. The
absence of S1PR3 enhances both acute and chronic muscle
regeneration in vivo. Therefore, S1PR3 has a key role in controlling
satellite cell function, being amongst a cohort of receptors reg-
ulating satellite cell quiescence.Acknowledgements
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